Objectives Pharmacists are well positioned to identify patients at risk of overdose, dispense
naloxone, and counsel patients on appropriate use. In response to growing numbers of …

Policy Points This scoping review reveals a growing literature on the effects of certain state
opioid misuse prevention policies, but persistent gaps in evidence on other prevalent state …

Background The number of opioid-involved overdose deaths in the United States remains a
national crisis. The HEALing Communities Study (HCS) will test whether Communities That …

Background Prompt access to prescribed buprenorphine/naloxone films (BUP/NX) and
naloxone nasal spray (NNS) is vital for patients with opioid use disorder (OUD), but multiple …

Abstract Background and Aims Patients with opioid use disorder (OUD) must be able to
obtain prescribed buprenorphine/naloxone films (BUP/NX) and naloxone nasal spray (NNS) …

Importance Despite the increasingly important role of pharmacies in the implementation of
naloxone access laws, there is limited information on the impact of such laws at the local …

The opioid crisis represents one of the largest failures of our current health care system as it
continues to claim lives at an unprecedented rate and has caused a devastating range of …

Purpose Strategies for deploying clinical pharmacists to increase access to buprenorphine
in inpatient, outpatient and transitional care, and community practice settings are described …

Background Expanding access to naloxone is one of the most impactful interventions in
decreasing opioid-related mortality. However, state distribution rates of naloxone are …

Since 1999, annual opioid-related overdose (ORO) mortality has increased more than six-
fold. In response to this crisis, the US Department of Health and Human Services outlined a …